Research Update from Dr. McCleary-Wheeler targeting epigenetics in Lymphoma.
Latest News
Research Update End-Year 2 CHF-02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Research Update from Dr. Breen regarding aiding prognosis of Canine Diffuse Large B-Cell Lymphoma.
Research Update End-Year 2 CHF-02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs
Research Update from Dr. Trepanier on genetic and environmental risks of lymphoma in Boxer dogs.
Research Update End-Year 2 CHF-02322: Analysis of the Health, Behavioral, and Longevity Data Collected in the 9/11 Medical Surveillance Longitudinal Study
Research Update from Dr. Otto from longevity study of 9/11 dogs.
Research Update Mid-Year 2 CHF-02383: Identifying Cellular Mechanisms of Inflammation During Canine Tick-Borne Diseases
Research Update from Dr. Petersen into Tick-Borne Disease.
Research Update Mid-Year 2 CHF-02403-MOU: Microphthalmia and Delayed Growth Syndrome in the Portuguese Water Dog
Research update from Dr. Casal on the project looking at what is commonly known as PES in our breed.
Research Update End Year 1 CHF-02428: Identifying the Disease-Defining Autoantibodies in Canine Addison’s Disease
Research update from year 1 of Dr. Friedenberg’s work with Addison’s Disease.
Research Update End Year 1 CHF-02441: Evaluation of a New Vaccine for Canine Brucellosis
Research update from Dr. Arenas for year 1 of work to develop a vaccine for canine brucellosis.
Research Update End-Year-1: CHF-02488: Addison’s Disease and Symmetrical Lupoid Onychodystrophy in Bearded Collies Provide Common Ground for Identifying Susceptibility Loci Underlying Canine Autoimmune Disorders
Research update from Dr. Oberbauer into identifying loci of gene for susceptibility to Addison’s Disease
Research Update End-Year-1 CHF-02489: Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes
Research Update from Dr. Volk for improving outcomes of mammary gland tumor treatment with targeted therapies.
